⌘K

12:37:55·17d

SECFilingvia Quantisnow

Amendment: SEC Form SCHEDULE 13D/A filed by Sol-Gel Technologies Ltd.

ByQuantisnow·Wall Street's wire, on your screen.

SLGL· Sol-Gel Technologies Ltd.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

SLGL
Sol-Gel Technologies Ltd.
Health Care

Recent analyst ratings

Aug 19UpdateRaymond James$4.00
Oct 21UpdateJefferies$5.50
Nov 15UpdateHC Wainwright & Co.$20.00
Nov 12UpdateRaymond James$21.00
Jul 28UpdateHC Wainwright & Co.$21.00
Jul 12UpdateHC Wainwright & Co.$20.00

Related

SEC31d
SEC Form SCHEDULE 13G filed by Sol-Gel Technologies Ltd.
SEC39d
SEC Form 6-K filed by Sol-Gel Technologies Ltd.
SEC39d
SEC Form 424B5 filed by Sol-Gel Technologies Ltd.
INSIDER39d
SEC Form 4 filed by Opaleye Management Inc.
SEC39d
SEC Form EFFECT filed by Sol-Gel Technologies Ltd.
PR39d
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
SEC39d
Amendment: SEC Form SCHEDULE 13G/A filed by Sol-Gel Technologies Ltd.
SEC44d
SEC Form POS AM filed by Sol-Gel Technologies Ltd.